UK - Imperial Innovations leads £2m Cell Medica funding

Imperial Innovations invested £1.16m to the round and appointed investment manager Maina Bhaman to the company's board.

Launched in 2007 with funding from Imperial Innovations and the Wellcome Trust, Cell Medica is commericalising clinically proven cell therapy techniques, some of which are developed at Imperial College London. The company's lead clinical application involves the transfer of donor-derived virus-specifc T cells into a patient in order to prevent infections following bone marrow transplant.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• UK / Ireland